These findings uncover alternative mechanisms of BCL-2 mediated chemoresistance, beyond its known anti-apoptotic activity, providing a rationale for novel combination strategies for BCL-2 positive DLBCL. Here, BCL2 is linked to diffuse large B-cell lymphoma.